These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 34097036)

  • 1. Calcifediol Treatment and COVID-19-Related Outcomes.
    Nogues X; Ovejero D; Pineda-Moncusí M; Bouillon R; Arenas D; Pascual J; Ribes A; Guerri-Fernandez R; Villar-Garcia J; Rial A; Gimenez-Argente C; Cos ML; Rodriguez-Morera J; Campodarve I; Quesada-Gomez JM; Garcia-Giralt N
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4017-e4027. PubMed ID: 34097036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.
    Oristrell J; Oliva JC; Casado E; Subirana I; Domínguez D; Toloba A; Balado A; Grau M
    J Endocrinol Invest; 2022 Jan; 45(1):167-179. PubMed ID: 34273098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
    Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
    BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients.
    Diaz-Curiel M; Cabello A; Arboiro-Pinel R; Mansur JL; Heili-Frades S; Mahillo-Fernandez I; Herrero-González A; Andrade-Poveda M
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105928. PubMed ID: 34091026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study.
    Alcala-Diaz JF; Limia-Perez L; Gomez-Huelgas R; Martin-Escalante MD; Cortes-Rodriguez B; Zambrana-Garcia JL; Entrenas-Castillo M; Perez-Caballero AI; López-Carmona MD; Garcia-Alegria J; Lozano Rodríguez-Mancheño A; Arenas-de Larriva MDS; Pérez-Belmonte LM; Jungreis I; Bouillon R; Quesada-Gomez JM; Lopez-Miranda J
    Nutrients; 2021 May; 13(6):. PubMed ID: 34064175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study.
    Entrenas-Castillo M; Entrenas-Costa LM; Pata MP; Jurado-Gamez B; Muñoz-Corroto C; Gomez-Rebollo C; Mira-Padilla E; Bouillon R; Quesada-Gómez JM
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment With 25-Hydroxyvitamin D
    Maghbooli Z; Sahraian MA; Jamalimoghadamsiahkali S; Asadi A; Zarei A; Zendehdel A; Varzandi T; Mohammadnabi S; Alijani N; Karimi M; Shirvani A; Holick MF
    Endocr Pract; 2021 Dec; 27(12):1242-1251. PubMed ID: 34653608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes.
    Bychinin MV; Klypa TV; Mandel IA; Andreichenko SA; Baklaushev VP; Yusubalieva GM; Kolyshkina NA; Troitsky AV
    J Nutr; 2021 Aug; 151(8):2199-2205. PubMed ID: 33982128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of malnutrition among hospitalised coronavirus disease 2019 (COVID-19) patients is associated with mortality and other clinical outcomes.
    Guðnadóttir SD; Gunnarsdóttir I; Hernandez UB; Ingadóttir ÁR
    Clin Nutr ESPEN; 2024 Jun; 61():1-7. PubMed ID: 38777420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
    JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study.
    Giannini S; Passeri G; Tripepi G; Sella S; Fusaro M; Arcidiacono G; Torres MO; Michielin A; Prandini T; Baffa V; Aghi A; Egan CG; Brigo M; Zaninotto M; Plebani M; Vettor R; Fioretto P; Rossini M; Vignali A; Fabris F; Bertoldo F
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.
    De Smet D; De Smet K; Herroelen P; Gryspeerdt S; Martens GA
    Am J Clin Pathol; 2021 Feb; 155(3):381-388. PubMed ID: 33236114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Clinical Outcomes of Vitamin D Deficiency in COVID-19 Hospitalized Patients: A Retrospective Single-Center Analysis.
    Afaghi S; Esmaeili Tarki F; Sadat Rahimi F; Besharat S; Mirhaidari S; Karimi A; Alamdari NM
    Tohoku J Exp Med; 2021 Oct; 255(2):127-134. PubMed ID: 34645738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.
    Vassiliou AG; Jahaj E; Pratikaki M; Orfanos SE; Dimopoulou I; Kotanidou A
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33316914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.
    Herrera-Quintana L; Gamarra-Morales Y; Vázquez-Lorente H; Molina-López J; Castaño-Pérez J; Machado-Casas JF; Coca-Zúñiga R; Pérez-Villares JM; Planells E
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34207873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
    Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
    Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
    Dror AA; Morozov N; Daoud A; Namir Y; Yakir O; Shachar Y; Lifshitz M; Segal E; Fisher L; Mizrachi M; Eisenbach N; Rayan D; Gruber M; Bashkin A; Kaykov E; Barhoum M; Edelstein M; Sela E
    PLoS One; 2022; 17(2):e0263069. PubMed ID: 35113901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of high-dose parenteral vitamin D
    Güven M; Gültekin H
    Eur J Clin Nutr; 2021 Sep; 75(9):1383-1388. PubMed ID: 34302132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.